This site is still under construction.

Research news

Safety of anthroposophic medicines ensured!
Anthroposophic medicinal products (AMPs) are widely used in Europe and worldwide. A retrolective safety analysis of pharmacovigilance data included 99.4% (1596/1606) of all AMPs marketed in Germany during the study period 2010 - 2017. The relative frequency of adverse drug reactions for AMPs was 1.5 per million maximum daily doses sold. The vast majority of patients (91.9%) recovered or were recovering from adverse reactions and there were no reports of fatal outcomes. The original article with detailed results is published open access:

Further information on Anthroposophic Medicine